- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.9000 - Volume
200 - Avg. Volume
0 - Market Cap (intraday)
35.816M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Zero Gravity Solutions, Inc., an agricultural biotechnology company, focuses on the commercialization of technology derived from and designed for long term spaceflight and planetary colonization with applications to agriculture on earth. The company offers BAM-FX, an ionic nutrient delivery platform for food crops that deliver minerals and micronutrients systemically at the cellular level of a plant; and Directed Selection, which relates to the production and alteration of various novel stem cells with characteristics in the prolonged zero/micro gravity environment of the International Space Station. It patents its stem cells for commercial sale to third parties. The company was formerly known as ElectroHealing Technologies, Inc. and changed its name to Zero Gravity Solutions, Inc. in January 2013. Zero Gravity Solutions, Inc. was founded in 1983 and is headquartered in Boca Raton, Florida.
www.zerogsi.com17
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ZGSI
View MorePerformance Overview: ZGSI
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZGSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZGSI
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-277.64%
Return on Equity (ttm)
--
Revenue (ttm)
65.79k
Net Income Avi to Common (ttm)
-7.29M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
504.56k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-955.04k